NS-018 is a newly discovered, orally bioavailable, small-molecule inhibitor of JAK2 that is competitive with adenosine triphosphate (ATP). In this study, we describe the preclinical characterization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results